Bausch Health Companies (BHC) Cash from Financing Activities (2009 - 2026)

Bausch Health Companies has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$49.0 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 113.69% year-over-year to -$49.0 million; the TTM figure through Jun 2026 stood at -$1.1 billion (down 1121.3% YoY), while the FY2025 annual figure was -$742.0 million, up 14.52% from the prior year.
• Cash from Financing Activities came in at -$49.0 million for Q2 2026 at Bausch Health Companies, up from -$100.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$719.0 million in Q3 2025.
• Average Cash from Financing Activities over 5 years is -$42.1 million, with a median of -$131.0 million recorded in 2023.
• Year-over-year, Cash from Financing Activities jumped 5144.44% in 2023 and sank 376.47% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$276.0 million in 2022, then surged by 71.38% to -$79.0 million in 2023, then soared by 207.59% to $85.0 million in 2024, then slumped by 376.47% to -$235.0 million in 2025, then surged by 79.15% to -$49.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$49.0 million in Q2 2026, -$100.0 million in Q1 2026, and -$235.0 million in Q4 2025.